Royalty Pharma
RPRX
#621
Rank
C$56.47 B
Marketcap
C$98.22
Share price
-0.01%
Change (1 day)
77.98%
Change (1 year)

Earnings for Royalty Pharma (RPRX)

Earnings in 2026 (TTM): C$2.15 Billion

According to Royalty Pharma's latest financial reports the company's current earnings are C$2.61 Billion. In 2025 the company made an earning of C$2.33 Billion, an increase over its 2024 earnings that were of C$2.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Royalty Pharma from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$2.15 B-7.62%
2025 C$2.33 B4.79%
2024 C$2.22 B-17.54%
2023 C$2.69 B351.47%
2022 C$0.59 B-70.3%
2021 C$2.01 B-24.3%
2020 C$2.65 B-31.9%
2019 C$3.90 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
C$10.32 B 367.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.73 B 2,151.45%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.22 B-89.78%๐Ÿ‡บ๐Ÿ‡ธ USA